(NASDAQ: LEGN) Legend Biotech's forecast annual revenue growth rate of 42.96% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.38%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Legend Biotech's revenue in 2025 is $728,303,000.On average, 9 Wall Street analysts forecast LEGN's revenue for 2025 to be $370,082,398,435, with the lowest LEGN revenue forecast at $340,472,125,979, and the highest LEGN revenue forecast at $427,289,665,653. On average, 9 Wall Street analysts forecast LEGN's revenue for 2026 to be $577,669,363,339, with the lowest LEGN revenue forecast at $533,684,214,550, and the highest LEGN revenue forecast at $638,731,670,877.
In 2027, LEGN is forecast to generate $782,594,900,274 in revenue, with the lowest revenue forecast at $649,045,762,425 and the highest revenue forecast at $931,959,861,836.